Our mission is to ensure the generation of reliable and helpful vaccines.
Contact Us Manufacturing Unit Plot No 4, Phase-III, IDA Pashamylaram,
| Indication | For the active immunisation of healthy sheep and goats against Peste des Petits Ruminants (PPR). |
|---|---|
| Vaccination Programme |
|
| Pack Size & Storage |
|
Peste des Petits Ruminants (PPR), commonly known as goat plague, is a highly contagious viral disease affecting sheep and goats, causing severe respiratory and gastrointestinal illness with mortality rates approaching 100% in susceptible populations. The disease continues to impose substantial economic losses through mortality, reduced productivity, trade restrictions, and loss of valuable breeding stock.
Our live attenuated PPR vaccine is manufactured using advanced cell culture technology under stringent quality standards to provide safe, reliable and long-lasting protection against PPR virus. Designed for national vaccination programmes and routine prophylactic use, the vaccine supports effective disease control while contributing towards the global WOAH and FAO strategy for the progressive eradication of PPR.
| Indication | For the active immunisation of healthy sheep against Sheep Pox. |
|---|---|
| Vaccination Programme |
|
| Pack Size & Storage |
|
Sheep Pox is an economically important viral disease of sheep characterised by fever, widespread skin lesions, respiratory distress and significant reductions in wool, meat and reproductive performance. Outbreaks frequently result in severe production losses and restrictions on livestock movement and international trade.
Our live attenuated Sheep Pox vaccine is produced in cell culture under strict quality-controlled manufacturing conditions to provide effective protection against virulent field strains. The vaccine forms an essential component of preventive flock health programmes in endemic and high-risk regions.
| Indication | For the active immunisation of healthy goats against Goat Pox. |
|---|---|
| Vaccination Programme |
|
| Pack Size & Storage |
|
Goat Pox is a highly contagious viral disease affecting goats of all ages, causing fever, skin lesions, respiratory complications and considerable production losses. Young animals are particularly susceptible, with severe outbreaks resulting in high morbidity and mortality, reduced growth rates and restrictions on animal movement.
Our live attenuated Goat Pox vaccine is manufactured using modern cell culture technology to provide safe, effective and durable immunity against Goat Pox virus. The vaccine supports comprehensive herd health programmes and contributes to improved livestock productivity.
| Indication | For the active immunisation of healthy cattle and buffaloes against Haemorrhagic Septicaemia. |
|---|---|
| Vaccination Programme |
|
| Pack Size & Storage |
|
Haemorrhagic Septicaemia (HS) is an acute, highly fatal bacterial disease of cattle and buffaloes caused by Pasteurella multocida serotype B:2. The disease is characterised by high fever, severe respiratory distress, oedematous swelling of the throat and neck, and septicaemia, often leading to sudden death. Outbreaks commonly occur during the monsoon season and result in significant economic losses through mortality, reduced milk production, decreased draught power, and trade restrictions.
Our Haemorrhagic Septicaemia vaccine is an inactivated, adjuvanted bacterial vaccine manufactured under stringent quality standards to provide safe and reliable protection against field infections. Designed for routine preventive vaccination programmes, it plays a vital role in reducing disease incidence and improving livestock productivity in endemic regions.
| Indication | For the active immunisation of healthy cattle and buffaloes against Black Quarter (Blackleg). |
|---|---|
| Vaccination Programme |
|
| Pack Size & Storage |
|
Black Quarter (Blackleg) is an acute, infectious bacterial disease of cattle and buffaloes caused by Clostridium chauvoei. The disease primarily affects young, rapidly growing animals and is characterised by sudden onset of fever, painful muscular swelling, lameness, crepitating lesions, and rapid death. Black Quarter causes substantial economic losses due to mortality, reduced productivity, and decreased farm profitability.
Our Black Quarter vaccine is a high-quality inactivated bacterial vaccine produced under rigorous quality-controlled manufacturing conditions to provide dependable protection against Clostridium chauvoei. Routine vaccination significantly reduces disease occurrence and forms an essential component of comprehensive herd health management programmes.
| Indication | For the active immunisation of healthy sheep and goats against Enterotoxaemia caused by Clostridium perfringens Type D. |
|---|---|
| Vaccination Programme |
|
| Pack Size & Storage |
|
Enterotoxaemia, commonly known as Pulpy Kidney Disease, is a rapidly fatal bacterial disease of sheep and goats caused by the toxins produced by Clostridium perfringens Type D. The disease frequently affects fast-growing animals consuming nutrient-rich diets and may result in sudden death without prior clinical signs. Enterotoxaemia remains one of the most economically significant clostridial diseases in small ruminants worldwide.
Our Enterotoxaemia vaccine is an inactivated toxoid vaccine manufactured under stringent quality standards to stimulate strong protective immunity against the lethal toxins of Clostridium perfringens. The vaccine provides an effective and economical means of protecting flocks, reducing mortality, and improving animal productivity.
At Channel Biosciences Private Limited, we are passionate about improving animal health and wellbeing. As a producer of animal vaccines, we have a deep commitment to creating innovative solutions for the most pressing animal health challenges facing the world today. With a dedicated R&D team and a commitment to quality, we are proud to be a trusted partner for veterinarians and animal owners alike
